NASOPHARYNGEAL HN001
Study #HN001Randomized Phase II and Phase III Studies of Individualized for Nasopharyngeal Carcinoma Base on Biomarker Epstein Barr Virus (EBV) Deoxyriboncleic Acid (DNA).
Back To Clinical Trials
Randomized Phase II and Phase III Studies of Individualized for Nasopharyngeal Carcinoma Base on Biomarker Epstein Barr Virus (EBV) Deoxyriboncleic Acid (DNA).
Back To Clinical Trials